Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Feed Symbols: BNTX

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • General
  • Health Care
  • News

CDC Says Pfizer, BioNTech, Moderna’s Updated Bivalent COVID-19 Vaccines Helped Prevent Symptomatic Infections From XBB-Related Subvariants Of Omicron

By Michael Horton
Today, 10:59 AM
-Reuters

BNTX

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • Large Cap
  • News
  • Top Stories

COVID-19 Vaccine Strategy Might Follow The Influenza Shot Way, FDA To Decide Today

By Vandana Singh
Today, 10:59 AM
The FDA is considering a significant shift in the U.S.'s COVID-19 vaccine strategy to simplify vaccination against COVID-19.

BNTX

Read More
4 minute read
  • Biotech
  • Cryptocurrency
  • Earnings
  • FDA
  • General
  • Health Care
  • Large Cap
  • Markets
  • Media
  • Movers
  • News
  • Penny Stocks
  • Tech
  • Top Stories
  • Trading Ideas

Google Layoffs 12K Employees, Netflix’s Q4 Earnings And CEO Steps Down, FDA Rejects Eli Lilly’s Alzheimer’s Candidate: Top Stories Friday, Jan. 20

By Vandana Singh
Today, 10:59 AM
Here's a round-up of stories from around the globe and from various media outlets. Benzinga

ABB

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • Media
  • News

Israel Says No Stroke Risk Associated With Pfizer/BioNTech Updated COVID-19 Shots

By Vandana Singh
Today, 10:59 AM
Israel health ministry official said Isreal had not identified any evidence linking strokes to an updated coronavirus vaccine by Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX).

BNTX

Read More
2 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • Large Cap
  • News

US Health Agencies Investigate Preliminary COVID-19 Vaccine Safety Signal In Older People

By Vandana Singh
Today, 10:59 AM
The U.S.

BNTX

Read More
1 minute read
  • News

Chinese Officials Reported on Saturday 59,938 Covid Deaths In Hospitals Between December 8 And January 12, With Average Age Of 80.3 Years

By Charles Gross
Today, 10:59 AM
https://www.reuters.com/world/china/china-reports-59938-covid-related-hospital-deaths-since-dec-8-2023-01-14/

BNTX

Read More
1 minute read
  • General
  • Health Care
  • News

Pfizer Says There Is No Evidence To Conclude That Ischemic Stroke Is Associated With Use Of Co., BioNTech’s COVID-19 Vaccines

By Michael Horton
Today, 10:59 AM
-Reuters

BNTX

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • Legal
  • News
  • Politics

‘Chair Rodgers Statement On COVID-19 Vaccine Safety Signal’

By Benzinga Newsdesk
Today, 10:59 AM
https://republicans-energycommerce.house.gov/posts/chair-rodgers-statement-on-covid-19-vaccine-reports   House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-WA) issued the following statement after

BNTX

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • News

FDA Says Totality Of Data Currently Suggests That It Is Very Unlikely That The Signal In Vaccine Safety Datalink Represents A True Clinical Risk

By Benzinga Newsdesk
Today, 10:59 AM
- Reuters

BNTX

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • News

CDC And FDA Identify Preliminary Covid-19 Vaccine Safety Signal For Persons Aged 65 Years And Older; CDC’s Vaccine Safety Datalink Met Criteria To Prompt Investigation Into If Safety Concern For Ischemic Stroke In Ages 65+ Who Got Pfizer-BioNTech Covid…

By Benzinga Newsdesk
Today, 10:59 AM
- Reuters

BNTX

Posts navigation

Previous 1 2 3 … 92 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service